First Time Loading...

Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 46.16 CNY -0.04% Market Closed
Updated: May 4, 2024

Wall Street
Price Targets

Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd

Wall Street analysts forecast Jiangsu Hengrui Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 57.98 CNY with a low forecast of 40.5 CNY and a high forecast of 126 CNY.

Lowest
Price Target
40.5 CNY
12% Downside
Average
Price Target
57.98 CNY
26% Upside
Highest
Price Target
126 CNY
173% Upside
Jiangsu Hengrui Pharmaceuticals Co Ltd Competitors:
Price Targets
OCUL
Ocular Therapeutix Inc
156% Upside
4119
SCI Pharmtech Inc
14% Downside
CURA
Curaleaf Holdings Inc
29% Upside
605116
Aurisco Pharmaceutical Co Ltd
30% Upside
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
21% Upside
000020
Dongwha Pharm Co Ltd
65% Upside
GSK
GlaxoSmithKline PLC
12% Upside
AUROPHARMA
Aurobindo Pharma Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Jiangsu Hengrui Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's revenue is 14%. The projected CAGR for the next 4 years is 14%.

14%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Jiangsu Hengrui Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's operating income is 10%. The projected CAGR for the next 4 years is 39%.

10%
Past Growth
39%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Jiangsu Hengrui Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's net income is 13%. The projected CAGR for the next 3 years is 21%.

13%
Past Growth
21%
Estimated Growth
Estimates Accuracy
0%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's stock price target?
Price Target
57.98 CNY

According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 57.98 CNY with a low forecast of 40.5 CNY and a high forecast of 126 CNY.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's revenue is 14%. The projected CAGR for the next 4 years is 14%.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
39%

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's operating income is 10%. The projected CAGR for the next 4 years is 39%.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's net income is 13%. The projected CAGR for the next 3 years is 21%.